Cushing Syndrome, also known as hypercortisolism, is a condition characterized by abnormally high concentrations of the stress hormone cortisol in the blood. The diagnosis of hypercortisolism is both difficult and time-consuming, taking up to 6 months of tests. Using the enzyme 11ß-hydroxysteroid dehydrogenase 1 (11ß-HSD1), responsible for cortisol production, as a target, we are developing Reverse Transcriptase Quantitative Polymerase Chain Reaction (RT-qPCR) assays to quantify the expression levels. This is in an effort to establish a correlation with cortisol levels as an alternative for diagnosing Cushing's Syndrome.
Specifically, we are interested in the advancement of subjective forensic examinations by developing more objective methods using modern instrumentation. The current method employed for distance determination in firearms analysis is antiquated and depends on subjective visual evaluation of colorimetric tests that respond to inorganic components of gunshot residue (GSR). Thus, we are developing evidence extraction methods, along with chromatographic and spectroscopic methods for the analysis of both organic and inorganic components of GSR for the purpose of determining the distance a firearm was from the victim when discharged.
In the Forensic DNA discipline, Short Tandem Repeat (STR) analysis is the ‘Gold Standard’ for individualization. We are using routine molecular biology methods to reproduce a human STR profile in molecularly cloned bacteria to demonstrate the unreliability of STR analysis in individualization. We are also developing Real-Time PCR methods to distinguish between the identical STR profiles of a human and a human STR cloned bacterium.
With rising antibiotic resistance and the development of novel antibiotics a low priority, in collaboration with the Pelphrey Lab, we are performing density functional theory calculations, with the Becke-Style three parameter Lee-Yang-Parr correlation functional (B3LYP) and the 6-311+g(d,p) basis set, on novel antibacterial drug candidates based on diaminopyrimidines to evaluate their potential as inhibitors for bacterial dihydrofolate reductase (DHFR), an important enzyme involved in DNA and RNA synthesis.
Also, in collaboration with the Pelphrey Lab, we are heterologously expressing dihydrofolate reductase (DHFR) enzymes from multiple bacterial species for use in enzyme kinetics and inhibition studies with novel diaminopyrimidine-based antibiotic candidates with oxadiazole and triazole linkers.
This research project focuses on the development and optimization of analytical methods for the detection, separation, and quantification of synthetic cannabinoids in forensic samples. Using liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) and gas chromatography-mass spectrometry (GC-MS), we are developing robust workflows capable of distinguishing structurally similar analogs and detecting trace levels in complex matrices.
Copyright © 2025 Doctor Ngo Labs - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.